As part of the reduction in workforce plan, Kineta, Inc. terminated the employment of Shawn Iadonato, Ph.D. as Chief Executive Officer of the Company, effective as of March 1, 2024, without cause. Dr. Iadonato will continue to serve as a member of the Company?s Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.625 USD | +10.23% | +11.41% | -82.78% |
Apr. 08 | Kineta, Inc. Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 Vista-101 Clinical Trial | CI |
Mar. 21 | Earnings Flash (KA) KINETA Posts 2023 Revenue $5.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-82.78% | 7.09M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.77% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- KA Stock
- News Kineta, Inc.
- Kineta, Inc. Terminates Employment of Shawn Iadonato as CEO